1-phenoxy-4-(prop-1-en-1-yl)benzene | 60319-66-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-phenoxy-4-(prop-1-en-1-yl)benzene
• 英文别名: (E)-1-phenoxy-4-(prop-1-en-1-yl)benzene；1-phenoxy-4-[(E)-prop-1-enyl]benzene
• CAS: 60319-66-6
• 化学式: C₁₅H₁₄O
• 分子量: 210.276
• InChiKey: KMXNDIIXFIUZSH-QHHAFSJGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-phenoxy-4-(prop-1-en-1-yl)benzene 在 tris-(4-bromophenyl)aminium hexachloroantimonate 作用下， 以 二氯甲烷 为溶剂， 反应 0.08h， 以36%的产率得到1-[(1R,2S,3S,4R)-2,3-dimethyl-4-(4-phenoxyphenyl)cyclobutyl]-4-phenoxybenzene
  参考文献：
  名称：

  阳离子自由基与碳正离子传播聚合反应的机理区别。

  摘要：

  发现在三（4-溴苯基）ami六氯锑酸酯存在下，双[4-（1-丙烯基）苯基]醚的聚合是通过竞争阳离子自由基和碳阳离子途径而发生的。这些途径分别涉及环丁烷化和线性加成。提出并探讨了适合每种机械类型的方法。

  DOI：

  10.1021/jo972072n
• 作为产物：
  描述：

  1-(4-Phenoxy-phenyl)-propan-1-ol 在 三氯氧磷 作用下， 以 吡啶 为溶剂， 反应 2.0h， 生成 1-phenoxy-4-(prop-1-en-1-yl)benzene
  参考文献：
  名称：

  Mechanistic aspects of aminium salt-catalyzed Diels-Alder reactions: The substrate ionization step

  摘要：

  Substituent effects in the aminium salt catalyzed Diels-Alder reactions of 2,3-dimethyl-1,3-butadiene with a series of meta and para substituted beta-methylstyrenes are used to probe detailed mechanistic aspects of these reactions. Kinetic studies were carried out using two different aminium salt catalysts and also electrochemically, using anodic potentials corresponding to the oxidation potentials of the aminium salts. Substituent effects in the equilibrium oxidations of the styrene substrates to the corresponding cation radicals were also studied, via oxidation potential measurements. The results indicate rate determining one electron oxidation of the sytrenes to their cation radicals via an outer sphere electron transfer.

  DOI：

  10.1002/(sici)1099-1395(199608)9:8<529::aid-poc813>3.0.co;2-1

文献信息

• [EN] ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] ISOXAZOLINES EN TANT QU'INHIBITEURS DE L'HYDROLASE DES AMIDES D'ACIDES GRAS
  申请人：INFINITY PHARMACEUTICALS INC

  公开号：WO2010135360A1

  公开（公告）日：2010-11-25

  The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.

  本发明提供了式(I)的异噁唑啉FAAH抑制剂或其药用可接受形式，其中G、Ra、Rb、Rc和Rd中的每一个如本文所定义。本发明还提供了包括式(I)化合物或其药用可接受形式以及药用可接受赋形剂的药物组合物。本发明还提供了治疗FAAH介导疾病的方法，包括向需要的受试者施用式(I)化合物或其药用可接受形式的治疗有效量。
• Anti-Markovnikov Hydroazidation of Activated Olefins via Organic Photoredox Catalysis
  作者：Nicholas P. R. Onuska、Megan E. Schutzbach-Horton、José L. Rosario Collazo、David. A. Nicewicz

  DOI：10.1055/s-0039-1690691

  日期：2020.1

  bioactive and medicinally relevant molecules. Historically, the formal hydroazidation of simple activated olefins and styrenes has proven difficult due to the inherent propensity of these compounds to oligomerize. Herein is disclosed a method for the anti-Markovnikov hydroazidation of activated olefins, catalyzed by an organic acridinium salt under irradiation from blue LEDs. This method is applicable

  有机叠氮化物可作为伯胺的合成有用替代物，伯胺是生物活性和医学相关分子中普遍存在的官能团。从历史上看，由于这些化合物固有的低聚倾向，简单的活化烯烃和苯乙烯的正式氢化叠氮化已被证明是困难的。本文公开了一种在蓝色LED的照射下由有机吖啶鎓盐催化的活化烯烃的反马尔可夫尼科夫氢化叠氮化的方法。该方法适用于各种取代苯乙烯和末端苯乙烯以及几种乙烯基醚，以中等至优异的产率产生合成通用的氢化叠氮化产物。
• THIOXOTHIAZOLIDINE DERIVATIVE HAVING RAS FUNCTION INHIBITORY EFFECT
  申请人：Kataoka Tohru

  公开号：US20140194412A1

  公开（公告）日：2014-07-10

  The present invention provides an anticancer drug having a Ras function inhibitory action. The present invention provides a Ras function inhibitor comprising a compound represented by the formula (I′): wherein each symbol is as defined in the present specification, or a salt thereof.

  本发明提供一种具有Ras功能抑制作用的抗癌药物。 本发明提供一种包括由式(I′)表示的化合物的Ras功能抑制剂： 其中每个符号如本说明书中所定义，或其盐。
• ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
  申请人：Behnke Mark L.

  公开号：US20110028478A1

  公开（公告）日：2011-02-03

  The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, R a , R b , R c , and R d are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.

  本发明提供了式(I)的异噁唑烷FAAH抑制剂或其药学上可接受的形式，其中G、Ra、Rb、Rc和Rd的定义如本文所述。本发明还提供了包括式(I)化合物或其药学上可接受的形式和药学上可接受的赋形剂的制药组合物。本发明还提供了治疗FAAH介导的疾病的方法，包括向需要治疗的患者施用式(I)化合物或其药学上可接受的形式的治疗有效量。
• B(C ₆ F ₅ ) ₃ ‐Catalyzed <i>E</i> ‐Selective Isomerization of Alkenes
  作者：Betty A. Kustiana、Salma A. Elsherbeni、Thomas G. Linford‐Wood、Rebecca L. Melen、Matthew N. Grayson、Louis C. Morrill

  DOI：10.1002/chem.202202454

  日期：2022.11.11

  report the B(C6F5)3-catalyzed E-selective isomerization of alkenes. The transition-metal-free method is applicable across a diverse array of readily accessible substrates, accessing a broad range of synthetically useful products containing versatile stereodefined internal alkenes. Synthetic and computational mechanistic studies indicate that the isomerization proceeds along competing 1,2-hydride shift

  Move along !：在此，我们报道了 B(C 6 F 5 ) 3 -催化的E -烯烃选择性异构化。不含过渡金属的方法适用于各种易于获得的底物，可获得范围广泛的合成有用产品，其中包含多功能立体定义的内部烯烃。合成和计算机理研究表明，异构化沿着竞争性 1,2-氢化物转移和氢化物提取途径进行。